Join Growin Stock Community!

大學光3218.TW Overview

TW StockBiotech. & Medical
(No presentation for 3218)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

大學光(3218)Overall Performance

大學光(3218)AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

大學光(3218) PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

大學光(3218)Key Information

大學光(3218)Profile

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. Its clinic provides laser vision correction surgery for myopia, hyperopia, astigmatism, and presbyopia; intraocular lens surgery for presbyopia and cataract; phacoemulsification and femtosecond laser for cataract surgery; and myopia control services, as well as services for dry eyes, retinal detachment, macular degeneration, strabismus, amblyopia, and other eye diseases. The company also offers vision products and services, including a range of eyeglass frames, multifocal and progressive lenses for myopia and presbyopia, sunglasses, orthokeratology, rigid gas permeable lenses, regular/colored contact lenses, eye supplements, etc.; eye plastic and micro cosmetic surgery; and customized aesthetic medicine consulting. In addition, it engages in the provision of optometric, hospital management, and technical consultancy services; and sales and leasing of medical devices. Universal Vision Biotechnology Co., Ltd. was founded in 1992 and is based in Taipei, Taiwan.

大學光(3218)FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
9.27
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
59.06%
Net Margin
23.46%
Revenue Growth (YoY)
0.09%
Profit Growth (YoY)
-0.57%
3-Year Revenue Growth
9.09%
3-Year Profit Growth
8.00%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
9.27
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
Gross Margin
59.06%
Net Margin
23.46%
Revenue Growth (YoY)
0.09%
Profit Growth (YoY)
-0.57%
3-Year Revenue Growth
9.09%
3-Year Profit Growth
8.00%
default symbol

3218

大學光

130.50D

-3.07%

(-0.03)

  • When is 3218's latest earnings report released?

    The most recent financial report for 大學光 (3218) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 3218's short-term business performance and financial health. For the latest updates on 3218's earnings releases, visit this page regularly.

  • Where does 3218 fall in the P/E River chart?

    According to historical valuation range analysis, 大學光 (3218)'s current price-to-earnings (P/E) ratio is 9.8, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of 3218?

    According to the latest financial report, 大學光 (3218) reported an Operating Profit of 315.31M with an Operating Margin of 30.77% this period, representing a decline of 2.69% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 3218's revenue growth?

    In the latest financial report, 大學光 (3218) announced revenue of 1.02B, with a Year-Over-Year growth rate of -5.08%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 3218 have?

    At the end of the period, 大學光 (3218) held Total Cash and Cash Equivalents of 638.39M, accounting for 0.11 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 3218 go with three margins increasing?

    In the latest report, 大學光 (3218) achieved the “three margins increasing” benchmark, with a gross margin of 58.98%%, operating margin of 30.77%%, and net margin of 34.14%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 3218's profit trajectory and future growth potential.

  • Is 3218's EPS continuing to grow?

    According to the past four quarterly reports, 大學光 (3218)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 4.05. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 3218?

    大學光 (3218)'s Free Cash Flow (FCF) for the period is 61.55M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 64.62% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.